Simultaneous determination of isoniazid, rifampicin, levofloxacin in mouse tissues and plasma by high performance liquid chromatography-tandem mass spectrometry

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 878, Issue 24, 2010, Pages 2286-2291

  Fang, Ping Fei ^a   Cai, Hua Lin ^a,b   Li, Huan De ^a   Zhu, Rong Hua ^a   Tan, Qin You ^a,b   Gao, Wei ^a   Xu, Ping ^a   Liu, Yi Ping ^a   Zhang, Wen Yuan ^a   Chen, Yong Chang ^a   Zhang, Feng ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Isoniazid; Levofloxacin; Mass spectrometry; Plasma; Rifampicin; Tissue

Indexed keywords

ANALYTES; GATIFLOXACIN; GRADIENT ELUTION; HPLC SEPARATION; HPLC-MS/MS; INTERNAL STANDARDS; ISONIAZID; LEVOFLOXACIN; LIMITS OF DETECTION; LOWER LIMITS; MOBILE PHASE; MOUSE PLASMA; MOUSE TISSUES; PROTEIN PRECIPITATION; SIMULTANEOUS DETERMINATIONS; TISSUE HOMOGENATES;

CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOLOGY; HYDRAZINE; LIQUIDS; MASS SPECTROMETRY; METHANOL; ORGANIC ACIDS; PLASMAS;

TISSUE;

GATIFLOXACIN; ISONIAZID; LEVOFLOXACIN; METHANOL; RIFAMPICIN;

ACCURACY; ANIMAL TISSUE; ARTICLE; BRAIN; CALIBRATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ISOLATION; DRUG STRUCTURE; DRUG TISSUE LEVEL; ELUTION; FEMALE; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY; LIVER; LUNG; MALE; MOUSE; NONHUMAN; PRECIPITATION; PRIORITY JOURNAL; SMALL INTESTINE; TANDEM MASS SPECTROMETRY; TISSUE HOMOGENATE;

ANIMALS; ANTIBIOTICS, ANTITUBERCULAR; BRAIN CHEMISTRY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FLUOROQUINOLONES; INTESTINE, SMALL; ISONIAZID; KIDNEY; LEAST-SQUARES ANALYSIS; LIVER; LUNG; MALE; METHANOL; MICE; OFLOXACIN; REPRODUCIBILITY OF RESULTS; RIFAMPIN; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; TISSUE DISTRIBUTION;

EID: 77955420687     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2010.06.038     Document Type: Article

References (15)

1. Blumberg H.M., Burman W.J., Chaisson R.E., Daley C.L., Etkind S.C., Friedman L.N., Fujiwara P., Grzemska M., Hopewell P.C., Iseman M.D., Jasmer R.M., Koppaka V., Menzies R.I., O'Brien R.J., Reves R.R., Reichman L.B., Simone P.M., Starke J.R., Vernon A.A. Am. J. Respir. Crit. Care. Med. 2003, 167:603.
2. Vishnevskii B.I., Manicheva O.A., Vishnevskaia E.B., Mel'nikova N.N., Otten T.F. Probl. Tuberk. Bolezn. Legk. 2006, 11:18.
3. Fuentes Z.M., Caminero J.A. Arch. Bronconeumol. 2006, 42:194.
4. Pereira J. Rev. Port. Pneumol. 2004, 10:97.
5. Huisman M., Smit J., Schinkel A. Aids 2000, 14:237.
6. Thomas H., Coley H. Cancer Control 2003, 10:159.
7. Gollapudi S., Reddy M., Gangadharam P., Tsuruo T., Gupta S. Biochem. Biophys. Res. Commun. 1994, 199:1181.
8. Smith P.J., van Dyk J., Fredericks A. Int. J. Tuberc. Lung. Dis. 1999, 3:S325.
9. Walubo A., Smith P., Folb P.I. J. Chromatogr. B 1994, 658:391.
10. Glass B.D., Agatonovic-Kustrin S., Chen Y.J., Wisch M.H. J. Chromatogr. Sci. 2007, 45:38.
11. Song S.H., Jun S.H., Park K.U., Yoon Y., Lee J.H., Kim J.Q., Song J. Rapid. Commun. Mass. Spectrom. 2007, 21:1331.
12. Bao D., Truong T.T., Renick P.J., Pulse M.E., Weiss W.J. J. Pharm. Biomed. Anal. 2008, 46:723.
13. Calleja I., Blanco-Príeto M.J., Ruz N., Renedo M.J., Dios-Viéitez M. J. Chromatogr A 2004, 1031:289.
14. Guidance for Industry Bioanalytical Method Validation from FDA 2001, US Department of Health and Human Services, Food and Drug Administration, CDER, Rockville, USA.
15. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Anal. Chem. 2003, 75:3019.